Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

Key PointsArgenx recently announced Phase 3 results for Vyvgart Hytrulo in treating autoimmune myositis.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

Brent: Diplomatic progress weighs on prices – OCBC

OCBC Bank strategists Sim Moh Siong and Christopher Wong note that improved prospects for shipping through the Strait of Hormuz and diplomatic developments involving Iran and Oman have eased supply concerns, pushing Brent crude below USD90/bbl.

More from Wednesday 26 August →